ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர் Today - Breaking & Trending Today

Artificial intelligence system could help counter the spread of disinformation

Disinformation campaigns are not new think of wartime propaganda used to sway public opinion against an enemy. What is new, however, is the use of the internet and social media to spread these campaigns. The spread of disinformation via social medi ....

Steven Smith , Joseph Schlessinger , Edward Kao , Erika Mackin , Lincoln Laboratory , Technology Office , Proceedings Of The National Academy Sciences , Algorithms Group , Lincoln Laboratory Artificial Intelligence Software Architectures , Artificial Intelligence Software Architectures , Influence Operations , National Academy , Lincoln Scholars , West Point , ஸ்டீவன் ஸ்மித் , ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர் , லிங்கன் ஆய்வகம் , தொழில்நுட்பம் அலுவலகம் , செல்வாக்கு செயல்பாடுகள் , தேசிய கலைக்கழகம் , லிங்கன் அறிஞர்கள் , மேற்கு பாயஂட் ,

Artificial intelligence system could help counter the spread of disinformation

MIT Lincoln Laboratory researchers built the Reconnaissance of Influence Operations (RIO) system, which automatically detects and analyzes social media accounts that are spreading disinformation. ....

Steven Smith , Joseph Schlessinger , Edward Kao , Erika Mackin , Lincoln Laboratory , Technology Office , Proceedings Of The National Academy Sciences , Algorithms Group , Lincoln Laboratory Artificial Intelligence Software Architectures , Artificial Intelligence Software Architectures , Influence Operations , National Academy , Lincoln Scholars , West Point , Mit Lincoln Laboratory , Machine Learning , Artificial Intelligence , Social Media Misinformation , Influence Operations , Conspiracy Theories , Steven Smith , Rtificial Intelligence Software Architectures And Algorithms Group , Econnaissance Of Influence Operations Rio , Edward Kao , Erika Mackin , Joseph Schlessinger ,

Artificial intelligence system could help counter spread of disinformation

Massachusetts Institute of Technology
Disinformation campaigns are not new – think of wartime propaganda used to sway public opinion against an enemy. What is new, however, is the use of the internet and social media to spread these campaigns. The spread of disinformation via social media has the power to change elections, strengthen conspiracy theories, and sow discord.
Steven Smith, a staff member from MIT Lincoln Laboratory’s Artificial Intelligence Software Architectures and Algorithms Group, is part of a team that set out to better understand these campaigns by launching the Reconnaissance of Influence Operations (RIO) program. Their goal was to create a system that would automatically detect disinformation narratives as well as those individuals who are spreading the narratives within social media networks. Earlier this year, the team published a paper on their work in the Proceedings of the National Academy of Sciences and they received an R&D 100 award last fal ....

Steven Smith , Joseph Schlessinger , Edward Kao , Erika Mackin , Lincoln Laboratory , Technology Office , Proceedings Of The National Academy Sciences , Algorithms Group , Lincoln Laboratory Artificial Intelligence Software Architectures , Artificial Intelligence Software Architectures , Influence Operations , National Academy , Lincoln Scholars , West Point , ஸ்டீவன் ஸ்மித் , ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர் , லிங்கன் ஆய்வகம் , தொழில்நுட்பம் அலுவலகம் , செல்வாக்கு செயல்பாடுகள் , தேசிய கலைக்கழகம் , லிங்கன் அறிஞர்கள் , மேற்கு பாயஂட் ,

Inozyme Pharma Presents Preclinical Data Suggesting Utility of INZ-701 as a Potential Treatment for ABCC6 Deficiency

Message :
Required fields
BOSTON, May 07, 2021 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (Nasdaq: INZY), a rare disease biopharmaceutical company developing novel therapeutics for the treatment of abnormal mineralization, today presented preclinical data suggesting the utility of its lead clinical development candidate, INZ-701, as a potential treatment for ABCC6 Deficiency. The data, presented at the virtual European Calcified Tissue Society Annual Congress (ECTS, May 6-8), are the first to show that an enzyme replacement therapy (ERT) increased plasma pyrophosphate (PPi) levels and reduced calcification in an animal model of ABCC6 Deficiency.
ABCC6 Deficiency is a rare, inherited disorder that can present as generalized arterial calcification of infancy (GACI) type 2 in infants and as pseudoxanthoma elasticum (PXE) in children and adults. This is one of several disorders with significant decrease in plasma PPi levels, a potent regulator of mineralization. In patients ....

United States , Inozyme Pharma , Yves Sabbagh , Joseph Schlessinger , Alex Van Rees , Axel Bolte , Stefan Riley , Pseudoxanthoma Elasticum , Demetrios Braddock , Exchange Commission , Yale University , European Calcified Tissue Society Annual Congress , Inozyme Pharma Inc , Thomas Jefferson University , Senior Vice President , Chief Scientific Officer , Thomas Jefferson , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , ஐவ் சப்பாக் , ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர் , அலெக்ஸ் வேன் ரீஸ் , அச்சு போல்ட் , ஸ்டீபன் ரைலி , டெமெட்ரியஸ் பிராடாக் , பரிமாற்றம் தரகு ,

Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting

Inozyme Pharma to Present Burden of Illness Data at the 2021 ACMG Annual Clinical Genetics Meeting
BOSTON, April 08, 2021 (GLOBE NEWSWIRE) Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases of abnormal mineralization, today announced that data from the burden of illness in infantile onset ABCC6 and ENPP1 deficiency study will be presented at the American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting taking place April 13-16, 2021.
The following poster presentation will be available during the ACMG Annual Clinical Genetics Meeting beginning on Wednesday, April 14, 2021, at 7:00 a.m. ET: ....

United States , Inozyme Pharma , Axel Bolte , Joseph Schlessinger , Alex Van Rees , Demetrios Braddock , Exchange Commission , Yale University , Inozyme Pharma Inc , American College Of Medical Genetics , American College , Medical Genetics , Annual Clinical Genetics Meeting , Clinical Genetics Meeting , Infantile Onset , Private Securities Litigation Reform Act , ஒன்றுபட்டது மாநிலங்களில் , அச்சு போல்ட் , ஜோசப் ஸ்சிலஎஸ்ஸிங்கேர் , அலெக்ஸ் வேன் ரீஸ் , டெமெட்ரியஸ் பிராடாக் , பரிமாற்றம் தரகு , யேல் பல்கலைக்கழகம் , அமெரிக்கன் கல்லூரி ஆஃப் மருத்துவ ஜெநெடிக்ஸ் , அமெரிக்கன் கல்லூரி , மருத்துவ ஜெநெடிக்ஸ் ,